Guildford, United Kingdom, April 10, 2006 - IDBS today announced that Pfizer Global R&D has licensed the IDBS BioBookTM global electronic experiment and study management software. BioBook is being deployed across the full spectrum of research biology; including discovery biology, worldwide safety sciences, pharmacokinetics dynamics and metabolism, and secondary and safety pharmacology. Users of BioBook can manage every aspect of their complex late stage research. As part of the global contract, BioBook will be used across all of Pfizer's research sites worldwide, with IDBS delivering implementation and support services.
Over two hundred life science R&D organisations around the world use IDBS enterprise data management solutions to drive their research, including 18 of the top 20 pharmaceutical and biotechnology companies.
IDBS is a leading provider of integrated software solutions to the life sciences industry. Maximising the value of research data by enabling organisations to capture, store, share and use data efficiently and effectively, whilst protecting intellectual property across the spectrum of discovery activities.
Headquartered in Guildford, UK, IDBS has U.S. offices in California, New Jersey and Massachusetts. IDBS partners with CTC Laboratory Systems in Japan and a network of distributors to market IDBS products and services in Asia. Founded in 1989, IDBS employs more than 150 people worldwide.
Danielle Guinebertiere, IDBS Communications Director
Tel: +1-617-547-2500 ext 230
Email: dguinebertiere@idbs.com
IDBS were chosen as a partner for the power and functionality of their software.
Professor Steven Ley
CBE, FRS, University of Cambridge